Concepedia

Ming‐Celine Dubosq

MD

Statistics

Publications

5

Citations

521

H-Index

5

Active since

2013

Affiliations

Westmead Hospital(Current)

The University of Sydney

Westmead Institute for Medical Research

South Australia Pathology

Children's Hospital at Westmead

Ming‐Celine Dubosq is an author at Westmead Hospital specializing in immunology, transplant immunology, and allogeneic stem cell therapy.

Publications per year

2013–2021

5

Publications

5

Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

Emily Blyth, Leighton Clancy, Renee Simms et al. · Blood · 2013 · 231 citations

Medicine, Immunology, Pharmacotherapy +16

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells

Barbara Withers, Emily Blyth, Leighton Clancy et al. · Blood Advances · 2017 · 141 citations · Full text

Medicine, Hematology, Immunology +17

Low-cost generation of Good Manufacturing Practice–grade CD19-specific chimeric antigen receptor–expressing T cells using piggyBac gene transfer and patient-derived materials

Saumya Ramanayake, Ian Bilmon, David Bishop et al. · Cytotherapy · 2015 · 91 citations

Life Sciences, Biotechnology, Immunology +15

Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant

David Gottlieb, Leighton Clancy, Barbara Withers et al. · Clinical & Translational Immunology · 2021 · 44 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A phase III randomized trial of high‐dose CEOP + filgrastim versus standard‐dose CEOP in patients with non‐Hodgkin lymphoma: 10‐year follow‐up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial

Mark Hertzberg, Jane Matthews, Janey M. Stone et al. · American Journal of Hematology · 2014 · 14 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

1–5 of 5